全球15位全球制药公司通过Anaplan简化其财务流程

看视频

在我们最大的单位中,我们已经缩短了一个月的计划周期。

财务,预算和医疗和发展控制的高级总监


挑战

临床试验项目可以持续十年的大部分时间,并且在制药行业中,财务计划需要考虑到试验寿命和年度财政预算。对于全球15家全球制药公司的金融团队来说,他们不仅需要一种更好的方法来访问和巩固其在全球范围内的数据,而且还需要使高级领导能够了解宝贵的实时见解和投资机会。

Solution

As a global company, the Senior Director of Finance, Budget, and Control for Medical and Development sought out a tool that could help them consolidate financial and resource data more efficiently and provide a comprehensive view of planning to company executives. The search led them to Anaplan-a flexible platform that allowed them to roll out global planning models.



Results

在实施Anaplan平台后,该公司将其最大部门的财务计划周期减少了整整一个月。该平台为组织的各个级别提供了可见性,以提高透明度和协作。通过用Anaplan平台替换其手动报告和整合流程,其分析师现在有更多时间专注于临床和资源分析,干预措施和投资决策,以更快地将产品推向市场。

为什么是Anaplan

我在全球制药市场,竞争s aggressive. As competitive advantages become progressively sparse, global operations need to be agile and manage change effectively and quickly. For the finance team at this pharmaceutical company, the Anaplan platform has provided them with the flexibility, real-time insight, and analytical capabilities to achieve continued success amidst increasing competition.